Senior Director, Access Strategy & Marketing

USA (Remote)

$232K/yr – $290K/yrSenior LevelFull time

Posted 6 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own cross functional access strategy for a NSCLC portfolio, coach the Market Access team, and drive launch readiness, with a sharp focus on payer value messaging and compliant collaboration with Medical Affairs and Brand/Regulatory.

  • Access Strategy & Launch Readiness: Align with stakeholders on a three year plan and oversee senior level forums.
  • Team Leadership & Stakeholder Alignment: Build an Access Marketing team and coordinate with national accounts and payers.
  • Evidence & Compliance Collaboration: Shape data strategy and ensure materials meet regulatory guidelines while supporting brand goals.

Job Description

Responsibilities
  • Develop and align with cross-functional partners on the three-year access strategy across RevMed’s NSCLC portfolio.
  • Lead and coach team of Access Marketers.
  • Coordinate launch readiness efforts across Market Access team and represent Market Access in senior-level forums (i.e., cross-functional launch planning, labelling team, etc).
  • Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers.
  • Develop strong relationship with Medical Affairs to inform data strategy and evidence generation plan.
  • Partner with national account field team to inform strategy and materials development.
  • Work closely with Brand Marketing, Regulatory and Compliance to ensure all materials support brand goals and follow compliance guidelines.
Revolution Medicines logo

Revolution Medicines

3.5 Glassdoor

We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.

Founded in 2014
Redwood City, California, USA
817 employees (26 in marketing)
54% recommend to a friend
64% CEO approval

Traffic Signals

Monthly Visitors
50.4K
Traffic Source Mix
Search
39%
Direct
40.8%
Referral
7.9%
Social
11.8%
Paid
0.4%

Headcount Trend

Current headcount: ~817

Marketing Team

Marketing Team Size
26 (3% of company)
Median Career Experience
12 years
Median Tenure
1.5 years
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$2.3B
Last Raise
$250M
Post IPO Debt, 9 months ago

Funding History

  • Jun 2025
    Post IPO Debt • $250M
  • Dec 2024
    Post IPO Equity • $750M
  • Mar 2023
    Post IPO Equity • $323.6M

Recent News